In a sit-down interview (watch below) Pfizer insider Melissa Strickler leaked internal emails that show corporate executives telling staff to be secretive about the use of human fetal tissue in laboratory testing of the COVID vaccine.
The interview was released by Project Veritas as the fifth video in its COVID vaccine investigative series.
Pfizer’s Chief Scientific Officer, Philip Dormitzer, admits aborted fetus tissue is used in the company’s vaccine program, but that employees should just stick with Pfizer’s polished narrative omitting any mention of aborted fetal tissue to avoid any issues with the public.
“HEK293T cells, used for the IVE assay, are ultimately derived from an aborted fetus,” Dormitzer said.
“On the other hand, the Vatican doctrinal committee has confirmed that they consider it acceptable for Pro-Life believers to be immunized.
Pfizer’s official statement couches the answer well and is what should be provided in response to an outside inquiry.”
Vanessa Gelman, who serves as Pfizer’s Senior Director of Worldwide Research, encouraged staff to be careful when talking about human fetal cells in the company’s vaccine program.
“From the perspective of corporate affairs, we want to avoid having the information on fetal cells floating out there,” Gelman said.
“The risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want out there.
We have not received any questions from policy makers or media on this issue in the last few weeks, so we want to avoid raising this if possible,” she said.